Company / SG&A per Share
SOLENO THERAPEUTICS INC SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.52
FY2025
5-year range
$0.82 / $2.63
FY2021-FY2025
Trend
-4.3%
vs FY2024
Sector context
#71 of 208
Health Care
What the data says
At $2.52, SOLENO THERAPEUTICS INC's sg&a per share ranks #138 of 208 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.14 in FY2020 to $2.63 in FY2024.
Based on SEC 10-K filings.
2.52 in FY2025 with a 5-year CAGR of +78.3%.
Increased from $0.82 to $2.52 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +29.1%
- 5-Year CAGR
- +78.3%
- 10-Year CAGR
- -
Sector benchmark
#138 of 208 in Health CareTop 66% of 208This company $2.52 Sector average $29.78
▼
-91.5% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 4.3% year-over-year.
- Ranks #71 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.52 | -4.3% |
| FY2024 | $2.63 | +222.3% |
| FY2023 | $0.82 | -30.3% |
| FY2022 | $1.17 | -42.3% |
| FY2021 | $2.03 | +1352.9% |
| FY2020 | $0.14 | -31.1% |
| FY2019 | $0.20 | -35.1% |
| FY2018 | $0.31 | -57.4% |
| FY2017 | $0.73 | +69.2% |
| FY2016 | $0.43 | -52.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026